The advertisements contain a Quick Response (QR) Code enabling direct access to the unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter ended June 30, 2026. These results were approved by the Board of Directors at its meeting held on August 08, 2026, on recommendation of the audit committee.
A copy of this disclosure has been updated on the company website at www.akums.in. The full Financial Results along with the Limited Review Report are available on the stock exchange websites at www.bseindia.com and www.nseindia.com, and also posted on the company website at www.akums.in/investors/financial-report/.
The document was digitally signed by Dharamvir Malik, Company Secretary & Compliance Officer, on August 10, 2026 at 15:03:25 +05'30'.
Note: The data provided also contains financial results and notices from other companies (Powerica Limited, Advanced Enzyme Technologies Limited, Vivriti Capital Limited, Delhivery Limited, etc.) and SARFAESI notices from various financial institutions, but the primary disclosure is from Akums Drugs and Pharmaceuticals Limited regarding their quarterly results publication compliance.